Medexus Pharmaceuticals Inc. (MDP.TO)
CAD 2.76
(-1.43%)
CAD 2.76
(-1.43%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.01 USD | -116.0% |
| 2022 | 0.06 USD | 140.0% |
| 2021 | -0.15 USD | 91.94% |
| 2020 | -1.86 USD | -500.0% |
| 2019 | -0.31 CAD | 36.73% |
| 2018 | -0.49 CAD | -4.26% |
| 2017 | -0.47 CAD | -67.86% |
| 2016 | -0.28 CAD | 24.32% |
| 2015 | -0.37 CAD | 44.78% |
| 2014 | -0.67 CAD | -865.42% |
| 2013 | -0.07 CAD | 74.3% |
| 2012 | -0.27 CAD | -33650.0% |
| 2011 | -0.00 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.11 USD | 90.48% |
| 2023 Q4 | 0.04 USD | 290.05% |
| 2023 Q3 | -0.02 USD | 58.69% |
| 2023 Q2 | -0.05 USD | -278.33% |
| 2023 Q1 | 0.03 USD | -91.18% |
| 2023 FY | - USD | -116.0% |
| 2022 Q1 | -0.07 USD | 73.04% |
| 2022 Q2 | -0.14 USD | -99.71% |
| 2022 Q3 | -0.08 USD | 46.29% |
| 2022 Q4 | 0.34 USD | 552.13% |
| 2022 FY | - USD | 140.0% |
| 2021 FY | - USD | 91.94% |
| 2021 Q2 | 0.53 USD | 255.88% |
| 2021 Q3 | -0.06 USD | -111.0% |
| 2021 Q1 | -0.34 USD | 0.0% |
| 2021 Q4 | -0.26 USD | -345.97% |
| 2020 Q3 | -0.93 CAD | -830.0% |
| 2020 Q4 | - USD | 100.0% |
| 2020 Q2 | -0.10 CAD | 58.33% |
| 2020 Q1 | -0.24 CAD | 0.0% |
| 2020 FY | - USD | -500.0% |
| 2019 Q1 | -0.11 CAD | 0.0% |
| 2019 Q3 | -0.14 CAD | -470.37% |
| 2019 Q2 | 0.04 CAD | 134.36% |
| 2019 FY | - CAD | 36.73% |
| 2019 Q4 | - CAD | 100.0% |
| 2018 Q1 | -0.09 CAD | 0.0% |
| 2018 Q4 | - CAD | 100.0% |
| 2018 FY | - CAD | -4.26% |
| 2018 Q3 | -0.07 CAD | 84.71% |
| 2018 Q2 | -0.48 CAD | -431.56% |
| 2017 Q1 | -0.16 CAD | 0.0% |
| 2017 Q3 | -0.14 CAD | -200.43% |
| 2017 Q4 | - CAD | 100.0% |
| 2017 FY | - CAD | -67.86% |
| 2017 Q2 | -0.05 CAD | 70.88% |
| 2016 Q2 | -0.13 CAD | -156.52% |
| 2016 FY | - CAD | 24.32% |
| 2016 Q1 | 0.23 CAD | 0.0% |
| 2016 Q4 | - CAD | 100.0% |
| 2016 Q3 | -0.16 CAD | -23.08% |
| 2015 FY | - CAD | 44.78% |
| 2015 Q4 | - CAD | 100.0% |
| 2015 Q3 | -0.19 CAD | -26.67% |
| 2015 Q2 | -0.15 CAD | 44.44% |
| 2015 Q1 | -0.27 CAD | 0.0% |
| 2014 Q1 | -0.16 CAD | 0.0% |
| 2014 FY | - CAD | -865.42% |
| 2014 Q4 | - CAD | 100.0% |
| 2014 Q2 | -0.22 CAD | -37.5% |
| 2014 Q3 | -0.20 CAD | 9.09% |
| 2013 Q3 | -1.16 CAD | -364.0% |
| 2013 FY | - CAD | 74.3% |
| 2013 Q1 | -0.01 CAD | 79.7% |
| 2013 Q2 | -0.25 CAD | -2948.78% |
| 2012 Q4 | -0.04 CAD | 96.69% |
| 2012 Q1 | -0.12 CAD | 69.23% |
| 2012 Q3 | -1.22 CAD | -3307.82% |
| 2012 FY | - CAD | -33650.0% |
| 2012 Q2 | -0.04 CAD | 70.17% |
| 2011 Q4 | -0.39 CAD | 0.0% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q2 | - CAD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aurora Cannabis Inc. | -1.60 CAD | 99.4% |
| Avicanna Inc. | -0.09 CAD | 89.689% |
| Avant Brands Inc. | -0.61 CAD | 98.426% |
| Cardiol Therapeutics Inc. | -0.44 CAD | 97.818% |
| Crescita Therapeutics Inc. | -0.10 CAD | 90.204% |
| Knight Therapeutics Inc. | -0.16 CAD | 94.0% |
| MediPharm Labs Corp. | -0.04 CAD | 73.333% |
| OrganiGram Holdings Inc. | -2.82 CAD | 99.66% |
| Canopy Growth Corporation | -8.79 CAD | 99.891% |
| Willow Biosciences Inc. | -0.10 CAD | 90.4% |
| Auxly Cannabis Group Inc. | -0.04 CAD | 78.619% |